The Pediatric infectious disease journal

Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccines in South Korean Teenagers

Updated

Abstract

Essence

In South Korean adolescents, NVX-CoV2373 was associated with lower medically attended COVID-19 risk than BNT162b2 after a third dose.

Evidence

A retrospective, propensity-score-matched database study of 12- to 18-year-olds estimated 180-day adjusted hazard ratios of 0.57 (0.31-1.05) for primary series and 0.68 (0.54-0.84) for third dose, comparing NVX-CoV2373 with BNT162b2.

Caveat

The primary-series comparison was small and not statistically significant, and residual confounding is possible because vaccine choice was not randomized.

Simplified

Key numbers

0.68
Lower Risk of Medically Attended COVID-19 (Third Dose)
for NVX-CoV2373 vs. BNT162b2 after a third dose
0.57
Lower Risk of Medically Attended COVID-19 (Primary Series)
for NVX-CoV2373 vs. BNT162b2 for the primary series

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

4 of 9
authors report competing interests
5 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free